Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Dual-action compounds targeting adenosine A2A receptor and adenosine transporter for prevention and treatment of neurodegenerative diseases

Dual-action compounds targeting adenosine A2A receptor and adenosine transporter for prevention and treatment of neurodegenerative diseases

US Patent 10342818 · Granted Jul 9, 2019

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Geometric 3D augmentations for transformer architectures2025
Pharmaceutical composition for promoting neurogenesis and method for promoting n2025
Compound with analgesic effect for use in prevention and treatment of pain2024
Compound with analgesic effect for use in prevention and treatment of pain2023
Pharmaceutical composition and extract of Dendrobii Caulis with eye care effect 2023
Method of making colloidal selenium nanoparticles2022
Method for treatment of cellular senescence2022
Method of making colloidal platinum nanoparticles2021
Bipartite molecules and uses thereof in treating diseases associated with abnorm2021
Method of making an inorganic platinum compound2020
Purine compounds possessing anticancer activity2020
Compounds for use in prevention and treatment of neurodegenerative diseases and 2019